Cargando…
Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs)
Sarcopenia is characterized by loss of muscle mass, altered muscle composition, fat and fibrous tissue infiltration, and abnormal innervation, especially in older individuals with immune-mediated rheumatic diseases (IMRDs). Several techniques for measuring muscle mass, strength, and performance have...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587967/ https://www.ncbi.nlm.nih.gov/pubmed/36125609 http://dx.doi.org/10.1007/s11547-022-01560-y |
_version_ | 1784814021623414784 |
---|---|
author | Salaffi, Fausto Carotti, Marina Di Matteo, Andrea Ceccarelli, Luca Farah, Sonia Villota-Eraso, Catalina Di Carlo, Marco Giovagnoni, Andrea |
author_facet | Salaffi, Fausto Carotti, Marina Di Matteo, Andrea Ceccarelli, Luca Farah, Sonia Villota-Eraso, Catalina Di Carlo, Marco Giovagnoni, Andrea |
author_sort | Salaffi, Fausto |
collection | PubMed |
description | Sarcopenia is characterized by loss of muscle mass, altered muscle composition, fat and fibrous tissue infiltration, and abnormal innervation, especially in older individuals with immune-mediated rheumatic diseases (IMRDs). Several techniques for measuring muscle mass, strength, and performance have emerged in recent decades. The portable dynamometer and gait speed represent the most frequently used tools for the evaluation of muscle strength and physical efficiency, respectively. Aside from dual-energy, X-ray, absorptiometry, and bioelectrical impedance analysis, ultrasound (US) and magnetic resonance imaging (MRI) techniques appear to have a potential role in evaluating muscle mass and composition. US and MRI have been shown to accurately identify sarcopenic biomarkers such as inflammation (edema), fatty infiltration (myosteatosis), alterations in muscle fibers, and muscular atrophy in patients with IMRDs. US is a low-cost, easy-to-use, and safe imaging method for assessing muscle mass, quality, architecture, and biomechanical function. This review summarizes the evidence for using US and MRI to assess sarcopenia. |
format | Online Article Text |
id | pubmed-9587967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-95879672022-10-24 Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs) Salaffi, Fausto Carotti, Marina Di Matteo, Andrea Ceccarelli, Luca Farah, Sonia Villota-Eraso, Catalina Di Carlo, Marco Giovagnoni, Andrea Radiol Med Magnetic Resonance Imaging Sarcopenia is characterized by loss of muscle mass, altered muscle composition, fat and fibrous tissue infiltration, and abnormal innervation, especially in older individuals with immune-mediated rheumatic diseases (IMRDs). Several techniques for measuring muscle mass, strength, and performance have emerged in recent decades. The portable dynamometer and gait speed represent the most frequently used tools for the evaluation of muscle strength and physical efficiency, respectively. Aside from dual-energy, X-ray, absorptiometry, and bioelectrical impedance analysis, ultrasound (US) and magnetic resonance imaging (MRI) techniques appear to have a potential role in evaluating muscle mass and composition. US and MRI have been shown to accurately identify sarcopenic biomarkers such as inflammation (edema), fatty infiltration (myosteatosis), alterations in muscle fibers, and muscular atrophy in patients with IMRDs. US is a low-cost, easy-to-use, and safe imaging method for assessing muscle mass, quality, architecture, and biomechanical function. This review summarizes the evidence for using US and MRI to assess sarcopenia. Springer Milan 2022-09-20 2022 /pmc/articles/PMC9587967/ /pubmed/36125609 http://dx.doi.org/10.1007/s11547-022-01560-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Magnetic Resonance Imaging Salaffi, Fausto Carotti, Marina Di Matteo, Andrea Ceccarelli, Luca Farah, Sonia Villota-Eraso, Catalina Di Carlo, Marco Giovagnoni, Andrea Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs) |
title | Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs) |
title_full | Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs) |
title_fullStr | Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs) |
title_full_unstemmed | Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs) |
title_short | Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs) |
title_sort | ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (imrds) |
topic | Magnetic Resonance Imaging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587967/ https://www.ncbi.nlm.nih.gov/pubmed/36125609 http://dx.doi.org/10.1007/s11547-022-01560-y |
work_keys_str_mv | AT salaffifausto ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds AT carottimarina ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds AT dimatteoandrea ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds AT ceccarelliluca ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds AT farahsonia ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds AT villotaerasocatalina ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds AT dicarlomarco ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds AT giovagnoniandrea ultrasoundandmagneticresonanceimagingasdiagnostictoolsforsarcopeniainimmunemediatedrheumaticdiseasesimrds |